Role of Glucagon, Catecholamines, and Growth Hormone in Human Glucose Counterregulation
Open accessThe DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Abstract
To further characterize mechanisms of glucose counterregulation in man, the effects of pharmacologically inducd deficiencies of glucagon, growth hormone, and catecholamines (alone and in combination) on recovery of plasma glucose from insulin-induced hypoglycemia and attendant changes in isotopically ([3-(3)H]glucose) determined glucose fluxes were studied in 13 normal subjects. In control studies, recovery of plasma glucose from hypoglycemia was primarily due to a compensatory increase in glucose production; the temporal relationship of glucagon, epinephrine, cortisol, and growth hormone responses with the compensatory increase in glucose appearance was compatible with potential participation of all these hormones in acute glucose counterregulation. Infusion of somatostatin (combined deficiency of glucagon and growth hormone) accentuated insulin-induced hypoglycemia (plasma glucose nadir: 36+/-2 ng/dl during infusion of somatostatin vs. 47+/-2 mg/dl in control studies, P < 0.01) and impaired restoration of normoglycemia (plasma glucose at min 90: 73+/-3 mg/dl at end of somatostatin infusion vs. 92+/-3 mg/dl in control studies, P<0.01). This impaired recovery of plasma glucose was due to blunting of the compensatory increase in glucose appearance since glucose disappearance was not augmented, and was attributable to suppression of glucagon secretion rather than growth hormone secretion since these effects of somatostatin were not observed during simultaneous infusion of somatostatin and glucagon whereas infusion of growth hormone along with somatostatin did not prevent the effect of somatostatin. The attenuated recovery of plasma glucose from hypoglycemia observed during somatostatin-induced glucagon deficiency was associated with plasma epinephrine levels twice those observed in control studies. Infusion of phentolamine plus propranolol (combined alpha-and beta-adrenergic blockade) had no effect on plasma glucose or glucose fluxes after insulin administration. However, infusion of somatostatin along with both phentolamine and propranolol further impaired recovery of plasma glucose from hypoglycemia compared to that observed with somatostatin alone (plasma glucose at end of infusions: 52+/-6 mg/dl for somatostatin-phentolamine-propranolol vs. 72+/-5 mg/dl for somatostatin alone, P < 0.01); this was due to further suppression of the compensatory increase in glucose appearance (maximal values: 1.93+/-0.41 mg/kg per min for somatostatin-phentolamine-propranolol vs. 2.86+/-0.32 mg/kg per min for somatostatin alone, P < 0.05). These results indicate that in man (a) restoration of normoglycemia after insulin-induced hypoglycemia is primarily due to a compensatory increase in glucose production; (b) intact glucagon secretion, but not growth hormone secretion, is necessary for normal glucose counterregulation, and (c) adrenergic mechanisms do not normally play an essential role in this process but become critical to recovery from hypoglycemia when glucagon secretion is impaired.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Feinleib, M., & Zar, J. H. (1975) · Journal of the American Statistical Association · doi:10.2307/2285423 · Cited by 12,680
Zar, J. H. (1996) · Cited by 7,837
MURPHY, B. E. P. (1967) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-27-7-973 · Cited by 1,994
Hypoglycemia: A Potent Stimulus to Secretion of Growth Hormone
Roth, J., Glick, S. M., Yalow, R. S., & Berson, S. A. (1963) · Science · doi:10.1126/science.140.3570.987 · Cited by 669
Neural control of the endocrine pancreas.
Woods, S. C., & Porte, D. (1974) · Physiological Reviews · doi:10.1152/physrev.1974.54.3.596 · Cited by 630
ON THE HORMONAL REGULATION OF CARBOHYDRATE METABOLISM; STUDIES WITH C14 GLUCOSE.
DeBodo, R. C., Steele, R., ALTSZULER, N., Dunn, A., & Bishop, J. (1963) · PubMed · Cited by 532
Tissue effects of glucocorticoids
Baxter, J. D., & Forsham, P. H. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90154-4 · Cited by 503
The Control of Glycogen Metabolism in the Liver
Hers, H. G. (1976) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.45.070176.001123 · Cited by 448
The control of glycogen metabolism in the liver
Hers, H. G., De Wulf, H., & Stalmans, W. (1970) · FEBS Letters · doi:10.1016/0014-5793(70)80569-5 · Cited by 414
Garber, A. J., Cryer, P. E., Santiago, J. V., Haymond, M. W., Pagliara, A. S., & Kipnis, D. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108460 · Cited by 351
Self-citation
Cited by
Items 401–420 of 420
Itoh, M., Reach, G., Furman, B. L., & Gerich, J. E. (1981) · Elsevier eBooks · doi:10.1016/b978-0-12-187820-7.50016-4 · Cited by 1
Self-citationGuelfi, K. J. (2006) · UWA Profiles and Research Repository (UWA)
Davey, R. J. (2010) · UWA Profiles and Research Repository (UWA)
Somatostatin Receptor Type 2 (SSTR2) Antagonism and Hypoglycemia in Diabetes
Yue, J. T. Y. (2012) · TSpace (University of Toronto)
Franz, I.-W. (1986) · Springer eBooks · doi:10.1007/978-3-642-70372-0_4
Hypoglycemia in Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_19 · Cited by 1
Self-citationFranz, I.-W. (1986) · Springer eBooks · doi:10.1007/978-3-642-71340-8_6
Meyer, C., Wittlin, S. D., & Gerich, J. E. (2004) · Springer eBooks · doi:10.1007/978-1-4757-6260-0_16
Self-citationHypoglycemia in Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_19-1
Self-citationTecilazich, F., Dinh, T. L., & Veves, A. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-158-5_4
Grossman, A. (1987) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(87)80062-9
Análisis dinámico de la glucemia
Trujillo-Arriaga, H. M. (2007) · doi:10.24275/uami.bc386j278
Gregnani, M. F., Budu, A., Batista, R. O., Ornellas, F. H., Estrela, G. R., Arruda, A. C., Freitas‐Lima, L. C., Kremer, J. L., Mendes, L. A. F., Casarini, D. E., et al. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.112085
Dynamic Tests in Clinical Endocrinology
Quarde, A. (2023) · Wiley eBooks · doi:10.1002/9781119863564.ch9
Les hypoglycémies iatrogènes : impacts immédiats et à long terme
Monnier, L., & Colette, C. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.02.001 · Cited by 1
Robertson, R. P. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-310-1_29 · Cited by 2
Puchkoff, J. E. (1997) · ScholarWorks at University of Montana · Cited by 1
Hipoglisemi Farkındalığında Bozulma ve Hemşirelik Yaklaşımları
Yeğin, G., & Karadağ, S. (2026) · Akdeniz Hemşirelik Dergisi · doi:10.59398/ahd.1728469
Glucose Metabolism and Hormonal Regulation
Christelle, G. (2026) · Endocrinology · doi:10.1007/978-3-030-71067-5_6-1
Metadata
- Authors
- Rizza, R. A., Cryer, P. E., & Gerich, J. E.
- Affiliations
- Mayo Clinic (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1979-07-01
- Volume
- 64
- Issue
- 1
- Pages
- 62-71
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC372091
- OpenAlex
- W1600232156
- Semantic Scholar
- 11f4079b84a608bc5984f3e84f9d0ccc73640319
- Cited by
- 421
- References
- 53
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 12 · 2017: 2 · 2016: 6 · 2015: 8 · 2014: 5 · 2013: 11 · 2012: 3
- FWCI
- 32.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- glucose counterregulation, insulin-induced hypoglycemia, glucagon, growth hormone, catecholamines, epinephrine, somatostatin, glucose appearance, glucose disappearance, glucose production, cortisol, adrenergic blockade, phentolamine, propranolol, glucose flux, glucagon deficiency, growth hormone deficiency
- MeSH terms
- Adrenergic alpha-Antagonists, Adrenergic beta-Antagonists, Adult, Blood Glucose, Catecholamines, Drug Interactions, Female, Glucagon, Humans, Hypoglycemia, Insulin, Male, Middle Aged, Phentolamine, Propranolol, Somatostatin, Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.